Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

@article{Taquet2021BidirectionalAB,
  title={Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA},
  author={Maxime Taquet and Sierra Luciano and John R. Geddes and Paul J. Harrison},
  journal={The Lancet. Psychiatry},
  year={2021},
  volume={8},
  pages={130 - 140}
}

Figures and Tables from this paper

How Different Pre-existing Mental Disorders and Their Co-occurrence Affects COVID-19 Clinical Outcomes? A Real-World Data Study in the Southern United States

There is an elevated risk of COVID-19-related hospitalization and death among participants with pre-existing mental disorders adjusting for key socio-demographic and comorbidity covariates and co-occurrence of any two clusters of mental disorders.

Factors Associated with COVID-19 Infection among a National Population of Individuals with Schizophrenia in the United States

Individuals with a diagnosis of schizophrenia were at substantial risk of COVID-19 infection, risk that was elevated for older adults and select social determinants, specifically African American race and Hispanic ethnicity.

Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States

Risk of COVID-19 infection was substantially higher among those with fewer economic resources, with greater medical and psychiatric comorbidity burden, and those who resided in African American or Hispanic communities; in contrast, individuals actively engaged in psychiatric treatment had substantially lower likelihood of infection.

Increased risk of psychiatric sequelae of COVID-19 is highest early in the clinical course

Patients who have recovered from COVID-19 are at an increased risk for developing new-onset mental illness, especially anxiety disorders, which is most prominent in the first 120 days following infection.

Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19

A higher COVID-19 mortality associated with concurrent antipsychotic medication use in older patients receiving behavioral health services is observed and the majority of patients in the geriatric clinic who recovered from CO VID-19 appeared to return to their pre-COVID psychiatric function.

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.

It is suggested that schizophrenia spectrum disorders may be a risk factor for mortality in patients with COVID-19 and adults with a schizophrenia spectrum disorder diagnosis were associated with an increased risk for mortality, but those with mood and anxiety disorders were not associated with a risk of mortality.

How different pre-existing mental disorders and their co-occurrence affects clinical outcomes of COVID-19? A study based on real-world data in the Southern United States

There is an elevated risk of COVID-19-related hospitalization and death among participants with pre-existing mental disorders adjusting for key socio-demographic covariates (i.e., age, gender, race, ethnicity, residence, smoking).
...

References

SHOWING 1-10 OF 33 REFERENCES

Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States

Individuals with a recent diagnosis of a mental disorder are identified as being at increased risk for COVID‐19 infection, which is further exacerbated among African Americans and women, and as having a higher frequency of some adverse outcomes of the infection.

OpenSAFELY: factors associated with COVID-19 death in 17 million patients

A range of clinical risk factors for COVID-19-related death is quantified in the largest cohort study conducted by any country to date and Black and South Asian people were at higher risk even after adjustment for other factors.

Factors associated with COVID-19-related death using OpenSAFELY

A range of clinical factors associated with COVID-19-related death is quantified in one of the largest cohort studies on this topic so far and includes people of white ethnicity, Black and South Asian people were at higher risk, even after adjustment for other factors.

Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies

There would be a case for considering routine pneumococcal immunisation for people with severe mental illness, based on the findings of this study, which estimated the risk of lobar pneumonia and otherneumococcal disease in people hospitalised with schizophrenia, bipolar disorder, depression or anxiety.